Your browser doesn't support javascript.
loading
Efficacy of antihyperglycemic therapies on cardiovascular and heart failure outcomes: an updated meta-analysis and meta-regression analysis of 35 randomized cardiovascular outcome trials.
Hasebe, Masashi; Yoshiji, Satoshi; Keidai, Yamato; Minamino, Hiroto; Murakami, Takaaki; Tanaka, Daisuke; Fujita, Yoshihito; Harada, Norio; Hamasaki, Akihiro; Inagaki, Nobuya.
Affiliation
  • Hasebe M; Department of Diabetes and Endocrinology, Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-Kofukai, Osaka, Japan.
  • Yoshiji S; Department of Diabetes and Endocrinology, Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-Kofukai, Osaka, Japan. yoshijis@kuhp.kyoto-u.ac.jp.
  • Keidai Y; Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. yoshijis@kuhp.kyoto-u.ac.jp.
  • Minamino H; Department of Human Genetics, McGill University, Montréal, QC, Canada. yoshijis@kuhp.kyoto-u.ac.jp.
  • Murakami T; Kyoto-McGill International Collaborative Program in Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan. yoshijis@kuhp.kyoto-u.ac.jp.
  • Tanaka D; Department of Diabetes and Endocrinology, Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-Kofukai, Osaka, Japan.
  • Fujita Y; Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Harada N; Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Hamasaki A; Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Inagaki N; Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
Cardiovasc Diabetol ; 22(1): 62, 2023 03 19.
Article de En | MEDLINE | ID: mdl-36935489
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies cardiovasculaires / Diabète de type 2 / Inhibiteurs du cotransporteur sodium-glucose de type 2 / Défaillance cardiaque Type d'étude: Clinical_trials / Diagnostic_studies / Risk_factors_studies / Systematic_reviews Limites: Humans Langue: En Journal: Cardiovasc Diabetol Sujet du journal: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Année: 2023 Type de document: Article Pays d'affiliation: Japon
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies cardiovasculaires / Diabète de type 2 / Inhibiteurs du cotransporteur sodium-glucose de type 2 / Défaillance cardiaque Type d'étude: Clinical_trials / Diagnostic_studies / Risk_factors_studies / Systematic_reviews Limites: Humans Langue: En Journal: Cardiovasc Diabetol Sujet du journal: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Année: 2023 Type de document: Article Pays d'affiliation: Japon